2,441
Views
14
CrossRef citations to date
0
Altmetric
Research Articles

Identification of promising antiviral drug candidates against non-structural protein 15 (NSP15) from SARS-CoV-2: an in silico assisted drug-repurposing study

ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon & ORCID Icon show all
Pages 438-448 | Received 23 Jun 2020, Accepted 20 Aug 2020, Published online: 04 Sep 2020

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Kateryna V. Miroshnychenko & Anna V. Shestopalova. (2022) Combined use of the hepatitis C drugs and amentoflavone could interfere with binding of the spike glycoprotein of SARS-CoV-2 to ACE2: the results of a molecular simulation study. Journal of Biomolecular Structure and Dynamics 40:19, pages 8672-8686.
Read now
Wael Alturaiki, Ayman Mubarak, Abduallah Al Jurayyan & Maged Gomaa Hemida. (2021) The pivotal roles of the host immune response in the fine-tuning the infection and the development of the vaccines for SARS-CoV-2. Human Vaccines & Immunotherapeutics 17:10, pages 3297-3309.
Read now

Articles from other publishers (12)

Md. Ariful Islam, Md. Kaderi Kibria, Md. Bayazid Hossen, Md. Selim Reza, Samme Amena Tasmia, Khanis Farhana Tuly, Md. Parvez Mosharof, Syed Rashel Kabir, Md. Hadiul Kabir & Md. Nurul Haque Mollah. (2023) Bioinformatics-based investigation on the genetic influence between SARS-CoV-2 infections and idiopathic pulmonary fibrosis (IPF) diseases, and drug repurposing. Scientific Reports 13:1.
Crossref
Bandhan Sarker, Md. Matiur Rahaman, Md. Ariful Islam, Muhammad Habibulla Alamin, Md. Maidul Husain, Farzana Ferdousi, Md. Asif Ahsan & Md. Nurul Haque Mollah. (2023) Identification of host genomic biomarkers from multiple transcriptomics datasets for diagnosis and therapies of SARS-CoV-2 infections. PLOS ONE 18:3, pages e0281981.
Crossref
Hayder M. Al-kuraishy, Ali I. Al-Gareeb, Engy Elekhnawy & Gaber El-Saber Batiha. (2022) Nitazoxanide and COVID-19: A review. Molecular Biology Reports 49:11, pages 11169-11176.
Crossref
Zheng Yao Low, Nur Zawanah Zabidi, Ashley Jia Wen Yip, Ashwini Puniyamurti, Vincent T. K. Chow & Sunil K. Lal. (2022) SARS-CoV-2 Non-Structural Proteins and Their Roles in Host Immune Evasion. Viruses 14:9, pages 1991.
Crossref
Kaifu Gao, Rui Wang, Jiahui Chen, Limei Cheng, Jaclyn Frishcosy, Yuta Huzumi, Yuchi Qiu, Tom Schluckbier, Xiaoqi Wei & Guo-Wei Wei. (2022) Methodology-Centered Review of Molecular Modeling, Simulation, and Prediction of SARS-CoV-2. Chemical Reviews 122:13, pages 11287-11368.
Crossref
Pawan K. Agrawal, Chandan Agrawal & Gerald Blunden. (2022) Artemisia Extracts and Artemisinin-Based Antimalarials for COVID-19 Management: Could These Be Effective Antivirals for COVID-19 Treatment?. Molecules 27:12, pages 3828.
Crossref
Prem Prakash Sharma, Meenakshi Bansal, Aaftaab Sethi, Poonam, Lindomar Pena, Vijay Kumar Goel, Maria Grishina, Shubhra Chaturvedi, Dhruv Kumar & Brijesh Rathi. (2021) Computational methods directed towards drug repurposing for COVID-19: advantages and limitations. RSC Advances 11:57, pages 36181-36198.
Crossref
Karen A. Gammeltoft, Yuyong Zhou, Carlos R. Duarte Hernandez, Andrea Galli, Anna Offersgaard, Rui Costa, Long V. Pham, Ulrik Fahnøe, Shan Feng, Troels K. H. Scheel, Santseharay Ramirez, Jens Bukh & Judith M. Gottwein. (2021) Hepatitis C Virus Protease Inhibitors Show Differential Efficacy and Interactions with Remdesivir for Treatment of SARS-CoV-2 In Vitro . Antimicrobial Agents and Chemotherapy 65:9.
Crossref
Mengran Wang, Johanna B Withers, Piero Ricchiuto, Ivan Voitalov, Michael McAnally, Helia N Sanchez, Alif Saleh, Viatcheslav R Akmaev & Susan Dina Ghiassian. (2021) A systems-based method to repurpose marketed therapeutics for antiviral use: a SARS-CoV-2 case study. Life Science Alliance 4:5, pages e202000904.
Crossref
Tatjana Schwarz, Kirsten Heiss, Yuvaraj Mahendran, Fiordiligie Casilag, Florian Kurth, Leif E. Sander, Clemens-Martin Wendtner, Manuela A. Hoechstetter, Marcel A. Müller, Renate Sekul, Christian Drosten, Volker Stadler & Victor M. Corman. (2021) SARS-CoV-2 Proteome-Wide Analysis Revealed Significant Epitope Signatures in COVID-19 Patients. Frontiers in Immunology 12.
Crossref
Sanjay Kumar Singh, Atul Kumar Upadhyay & M. Sudhakara Reddy. (2021) Screening of potent drug inhibitors against SARS-CoV-2 RNA polymerase: an in silico approach. 3 Biotech 11:2.
Crossref
Hongxin Yu, Chunyan Li, Xing Wang, Jingyi Duan, Na Yang, Lijuan Xie, Yu Yuan, Shanze Li, Chenghao Bi, Bin Yang & Yubo Li. (2020) Techniques and Strategies for Potential Protein Target Discovery and Active Pharmaceutical Molecule Screening in a Pandemic. Journal of Proteome Research 19:11, pages 4242-4258.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.